Benzodiazepines (Psy and mixed indications) updated on 02-10-2025

Congenital cataract

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17691
R74675		 Cifuentes - Alprazolam, 2025 Congenital cataract and lens anomalies 1st trimester case control unexposed (general population or NOS) Adjustment: No BZD Coexposure: Not specified 1.76 [0.25;12.63] C 1/94   1,360/223,913 1,361 94
ref
Total 1 studies 1.76 [0.25;12.63] 1,361 94
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Cifuentes - Alprazolam, 2025Cifuentes - Alprazolam, 2025 1.76[0.25; 12.63]1,361940%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate0.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0 case control studiescase control studies 1.76[0.25; 12.63]1,36194 -NACifuentes - Alprazolam, 2025 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.76[0.25; 12.63]1,36194 -NACifuentes - Alprazolam, 2025 1 Tags Adjustment   - No  - No 1.76[0.25; 12.63]1,36194 -NACifuentes - Alprazolam, 2025 1 BZD Coexposure   - Not specified  - Not specified 1.76[0.25; 12.63]1,36194 -NACifuentes - Alprazolam, 2025 1 All studiesAll studies 1.76[0.25; 12.63]1,36194 -NACifuentes - Alprazolam, 2025 10.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.76[0.25; 12.63]1,36194 -NACifuentes - Alprazolam, 2025 10.510.01.0